Nuoshen Pharma
纽欧申医药
Nuoshen Pharma
Biotech/Healthcare
NewOcean Pharmaceuticals develops innovative central nervous system drugs. The company operates dual platforms for adeno-associated virus (AAV) gene therapy and small-molecule therapeutics, providing innovation engines for both treatment modalities.
Latest round: Series B (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-09-03
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.